Mumbai-based neuroscience startup NeuroLeap has raised an undisclosed amount of funding from Rajashree Birla, chairperson, Aditya Birla centre for community initiatives & rural development and Sminu Jindal, managing director, Jindal Saw and founder chairperson Svayam.
“The investment by Birla and Jindal will encourage the company to grow its presence across the country,” said Kumaar Bagrodia, founder, NeuroLeap.
Founded in 2017 by Bagroadia, NeuroLeap uses an advanced brain-computer interface (BCI) technology to understand brain activity and help it perform at optimum potential without using any medication and with zero side effects.
NeuroLeap has centres in New Delhi and Mumbai. The startup claimed the centres have delivered brain enhancement for various areas like improving attention, calmness, sleep, memory and emotional health for people across age groups who may or may not have any mental disorders. It has also helped patients with mental health conditions such as anxiety, clinical depression, insomnia and attention deficit hyperactivity disorder (ADHD).
“This is the new age of brain enhancement and mental health, which is safe and technology-based. We have helped clients with various mental health disorders lead healthier, happier, fulfilling & enriched lives," Bagrodia said.
Mumbai-based NeuroLeap has also signed a memorandum of understanding with the Indian Institute of Technology, Palakkad for promoting research in BCI technology.
“NeuroLeap is successfully delivering better brain outcomes. Bagrodia is a visionary entrepreneur and is steadily building the future of mental health and wellness in India. I'm happy to invest in the venture which is leveraging innovative technology for a more advanced way to understand the brain and safely enhance it without pharma or medical interventions," Jindal said.